Cargando…
Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients
Systemic sclerosis (SSc or scleroderma) is an auto-immune disease characterized by skin fibrosis. While primary cells from patients are considered as a unique resource to better understand human disease biology, the effect of in vitro culture on these cells and their evaluation as a platform to iden...
Autores principales: | Chadli, Loubna, Sotthewes, Britt, Li, Kejie, Andersen, Stefan N., Cahir-McFarland, Ellen, Cheung, Marc, Cullen, Patrick, Dorjée, Annemarie, de Vries-Bouwstra, Jeska K., Huizinga, Tom W. J., Fischer, David F., DeGroot, Jeroen, Viney, Joanne L., Zheng, Timothy S., Aarbiou, Jamil, Gardet, Agnes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418101/ https://www.ncbi.nlm.nih.gov/pubmed/30872777 http://dx.doi.org/10.1038/s41598-019-41153-w |
Ejemplares similares
-
Rituximab in early systemic sclerosis
por: Boonstra, Maaike, et al.
Publicado: (2017) -
Anti-carbamylated protein antibodies in systemic sclerosis
por: Liem, Sophie I. E., et al.
Publicado: (2023) -
Myofibroblasts Are Not Characteristic Features of Keloid Lesions
por: Hahn, Jennifer M., et al.
Publicado: (2022) -
610 Myofibroblasts Are Not Characteristic Features of Keloid Lesions
por: Supp, Dorothy M, et al.
Publicado: (2022) -
Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study
por: van Leeuwen, Nina M., et al.
Publicado: (2020)